DAAM2_HUMAN - dbPTM
DAAM2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DAAM2_HUMAN
UniProt AC Q86T65
Protein Name Disheveled-associated activator of morphogenesis 2
Gene Name DAAM2 {ECO:0000312|HGNC:HGNC:18143}
Organism Homo sapiens (Human).
Sequence Length 1068
Subcellular Localization
Protein Description Key regulator of the Wnt signaling pathway, which is required for various processes during development, such as dorsal patterning, determination of left/right symmetry or myelination in the central nervous system. Acts downstream of Wnt ligands and upstream of beta-catenin (CTNNB1). Required for canonical Wnt signaling pathway during patterning in the dorsal spinal cord by promoting the aggregation of Disheveled (Dvl) complexes, thereby clustering and formation of Wnt receptor signalosomes and potentiating Wnt activity. During dorsal patterning of the spinal cord, inhibits oligodendrocytes differentiation via interaction with PIP5K1A. Also regulates non-canonical Wnt signaling pathway. Acts downstream of PITX2 in the developing gut and is required for left/right asymmetry within dorsal mesentery: affects mesenchymal condensation by lengthening cadherin-based junctions through WNT5A and non-canonical Wnt signaling, inducing polarized condensation in the left dorsal mesentery necessary to initiate gut rotation. Together with DAAM1, required for myocardial maturation and sarcomere assembly..
Protein Sequence MAPRKRSHHGLGFLCCFGGSDIPEINLRDNHPLQFMEFSSPIPNAEELNIRFAELVDELDLTDKNREAMFALPPEKKWQIYCSKKKEQEDPNKLATSWPDYYIDRINSMAAMQSLYAFDEEETEMRNQVVEDLKTALRTQPMRFVTRFIELEGLTCLLNFLRSMDHATCESRIHTSLIGCIKALMNNSQGRAHVLAQPEAISTIAQSLRTENSKTKVAVLEILGAVCLVPGGHKKVLQAMLHYQVYAAERTRFQTLLNELDRSLGRYRDEVNLKTAIMSFINAVLNAGAGEDNLEFRLHLRYEFLMLGIQPVIDKLRQHENAILDKHLDFFEMVRNEDDLELARRFDMVHIDTKSASQMFELIHKKLKYTEAYPCLLSVLHHCLQMPYKRNGGYFQQWQLLDRILQQIVLQDERGVDPDLAPLENFNVKNIVNMLINENEVKQWRDQAEKFRKEHMELVSRLERKERECETKTLEKEEMMRTLNKMKDKLARESQELRQARGQVAELVAQLSELSTGPVSSPPPPGGPLTLSSSMTTNDLPPPPPPLPFACCPPPPPPPLPPGGPPTPPGAPPCLGMGLPLPQDPYPSSDVPLRKKRVPQPSHPLKSFNWVKLNEERVPGTVWNEIDDMQVFRILDLEDFEKMFSAYQRHQKELGSTEDIYLASRKVKELSVIDGRRAQNCIILLSKLKLSNEEIRQAILKMDEQEDLAKDMLEQLLKFIPEKSDIDLLEEHKHEIERMARADRFLYEMSRIDHYQQRLQALFFKKKFQERLAEAKPKVEAILLASRELVRSKRLRQMLEVILAIGNFMNKGQRGGAYGFRVASLNKIADTKSSIDRNISLLHYLIMILEKHFPDILNMPSELQHLPEAAKVNLAELEKEVGNLRRGLRAVEVELEYQRRQVREPSDKFVPVMSDFITVSSFSFSELEDQLNEARDKFAKALMHFGEHDSKMQPDEFFGIFDTFLQAFSEARQDLEAMRRRKEEEERRARMEAMLKEQRERERWQRQRKVLAAGSSLEEGGEFDDLVSALRSGEVFDKDLCKLKRSRKRSGSQALEVTRERAINRLNY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
182AcetylationTSLIGCIKALMNNSQ
HHHHHHHHHHHCCCC
39.2720167786
355PhosphorylationMVHIDTKSASQMFEL
EEEECCCCHHHHHHH
34.93-
482PhosphorylationEKEEMMRTLNKMKDK
HHHHHHHHHHHHHHH
19.4528152594
487AcetylationMRTLNKMKDKLARES
HHHHHHHHHHHHHHH
54.017429263
512PhosphorylationAELVAQLSELSTGPV
HHHHHHHHHHCCCCC
25.1420071362
589PhosphorylationPQDPYPSSDVPLRKK
CCCCCCCCCCCCCCC
37.8220071362
656PhosphorylationRHQKELGSTEDIYLA
HHHHHHCCHHHHHHH
41.0530266825
657PhosphorylationHQKELGSTEDIYLAS
HHHHHCCHHHHHHHH
35.5630266825
661PhosphorylationLGSTEDIYLASRKVK
HCCHHHHHHHHHCCE
14.4524702127
664PhosphorylationTEDIYLASRKVKELS
HHHHHHHHHCCEEEE
30.0024702127
671PhosphorylationSRKVKELSVIDGRRA
HHCCEEEECCCCCHH
20.3723403867
747PhosphorylationARADRFLYEMSRIDH
HHHHHHHHHHHHHHH
13.5822817900
765AcetylationRLQALFFKKKFQERL
HHHHHHHHHHHHHHH
47.9519819117
766AcetylationLQALFFKKKFQERLA
HHHHHHHHHHHHHHH
54.3819819125
844PhosphorylationRNISLLHYLIMILEK
HHHHHHHHHHHHHHH
9.6322817900
1015PhosphorylationRKVLAAGSSLEEGGE
HHHHHCCCCCCCCCC
27.3329691806
1016PhosphorylationKVLAAGSSLEEGGEF
HHHHCCCCCCCCCCH
38.5926657352
1050PhosphorylationLKRSRKRSGSQALEV
HHHHHCCCCCCHHHH
45.9226657352
1052PhosphorylationRSRKRSGSQALEVTR
HHHCCCCCCHHHHHH
17.3326657352

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of DAAM2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DAAM2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DAAM2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
K1C40_HUMANKRT40physical
25416956
RBY1F_HUMANRBMY1Fphysical
25416956
KR107_HUMANKRTAP10-7physical
25416956
KR101_HUMANKRTAP10-1physical
25416956
KR108_HUMANKRTAP10-8physical
25416956
KR103_HUMANKRTAP10-3physical
25416956
SG2A1_HUMANSCGB2A1physical
28514442
AVR2A_HUMANACVR2Aphysical
28514442
CD320_HUMANCD320physical
28514442
PRAME_HUMANPRAMEphysical
28514442
LGR4_HUMANLGR4physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DAAM2_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP